Summary
Updated Aug 31, 2026
Efraim Cohen-Arazi is Director of REGENTIS BIOMATERIALS LTD. (RGNT). 1 SEC Form 4 filing on record, dated 13 July 2026.
Trading Pattern
InsiderAlpha's records for Efraim Cohen-Arazi go back to 2026: 1 primary Form 4 filing, an average of 1.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Most Active Insiders Right Now
Efraim Cohen-Arazi has no co-filers on record, so these are insiders with the largest open-market activity across the market in the last 90 days.
- George Kurtz - $103.78M of CRWD open-market activity in the last 90 days
- Stephen M. Bloch - $100.11M of LQDA open-market activity in the last 90 days
- J. Scott Sitra - $100.00M of SCTH open-market activity in the last 90 days
- Patrick Sean Neville - $99.65M of CRCL open-market activity in the last 90 days
- Jason P. Rhodes - $99.40M of DYN open-market activity in the last 90 days
- Catalyst4, Inc. - $98.71M of MPLT open-market activity in the last 90 days
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Efraim Cohen-Arazi?
Efraim Cohen-Arazi is a corporate insider, tracked as Director of REGENTIS BIOMATERIALS LTD. (RGNT). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Efraim Cohen-Arazi submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Efraim Cohen-Arazi's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Efraim Cohen-Arazi and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial